Literature DB >> 27592608

Codeine Shopping Behavior in a Retrospective Cohort of Chronic Noncancer Pain Patients: Incidence and Risk Factors.

Chouki Chenaf1, Jean-Luc Kabore2, Jessica Delorme2, Bruno Pereira3, Aurélien Mulliez3, Lucie Roche2, Alain Eschalier4, Noémie Delage5, Nicolas Authier4.   

Abstract

Codeine is a widely used opioid analgesic but studies on its misuse in chronic noncancer pain (CNCP) are still lacking. The aim of this study was to assess the incidence of codeine shopping behavior in CNCP patients and to identify the associated risk factors. This was a population-based retrospective cohort study from the French health insurance claims database from 2004 to 2014. The main outcome was the one-year incidence of codeine shopping behavior defined as ≥1 day of overlapping prescriptions written by ≥2 different prescribers and filled in ≥3 different pharmacies. A total of 1,958 CNCP patients treated with codeine were included, with a mean age of 62.7 ± 16.1 years, 36.8% men. The 1-year incidence rate of codeine shopping behavior was 4.03% (95% confidence interval [CI], 3.07-5.28). In multivariate analysis, risk factors associated with shopping behavior were younger age (≤40 years) (hazard ratio [HR] = 7.29; 95% CI, 4.28-12.42), mental health disorders (HR = 2.25; 95% CI, 1.08-4.67), concurrent use of anxiolytic benzodiazepines (HR = 3.12; 95% CI, 1.55-6.26), and previous use of strong opioids (HR = 2.94; 95% CI, 1.24-6.98). The incidence of codeine shopping behavior in CNCP patients was 4% and risk factors identified were shared with those of opioid abuse. PERSPECTIVE: Shopping behavior for codeine was not infrequent in CNCP patients. The risk factors identified in this study are similar to those identified for opioid abuse in other studies. Appropriate use of codeine from the perspectives of patients and healthcare providers should be encouraged. Copyright Â
© 2016 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic pain; codeine; doctor shopping; opioid analgesics; opioid misuse

Mesh:

Substances:

Year:  2016        PMID: 27592608     DOI: 10.1016/j.jpain.2016.08.010

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  5 in total

1.  Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use.

Authors:  Célian Bertin; Julien Bezin; Chouki Chenaf; Jessica Delorme; Nicolas Kerckhove; Antoine Pariente; Marie Tournier; Nicolas Authier
Journal:  Front Psychiatry       Date:  2022-06-30       Impact factor: 5.435

2.  Risk assessment of using off-label morphine sulfate in a population-based retrospective cohort of opioid-dependent patients.

Authors:  Célian Bertin; Jessica Delorme; Marie Riquelme; Hélène Peyrière; Georges Brousse; Alain Eschalier; Denis Ardid; Chouki Chenaf; Nicolas Authier
Journal:  Br J Clin Pharmacol       Date:  2019-08-24       Impact factor: 4.335

3.  Doctor shopping among chronic noncancer pain patients treated with opioids in the province of Quebec (Canada): incidence, risk factors, and association with the occurrence of opioid overdoses.

Authors:  Jean-Luc Kaboré; M Gabrielle Pagé; Lise Dassieu; Éric Tremblay; Mike Benigeri; Denis A Roy; Anaïs Lacasse; Manon Choinière
Journal:  Pain Rep       Date:  2021-09-16

4.  Opioid Doctor Shopping: A Rare Phenomenon Among Patients with Chronic Non-Cancer Pain Followed in Tertiary Care Settings.

Authors:  Jean-Luc Kaboré; Manon Choinière; Lise Dassieu; Anaïs Lacasse; M Gabrielle Pagé
Journal:  J Pain Res       Date:  2021-06-21       Impact factor: 3.133

5.  Identification of factors influencing tampering of codeine-containing medicines in England: a qualitative study.

Authors:  Andreas Kimergård; Stephen Parkin; Stacey Jennings; Eileen Brobbin; Paolo Deluca
Journal:  Harm Reduct J       Date:  2020-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.